Published in Antimicrob Agents Chemother on February 01, 2001
Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada. Antimicrob Agents Chemother (2001) 2.30
Life-threatening invasive Helcococcus kunzii infections in intravenous-drug users and ermA-mediated erythromycin resistance. J Clin Microbiol (2005) 1.23
Emergence of group A streptococcus strains with different mechanisms of macrolide resistance. Antimicrob Agents Chemother (2002) 1.21
New genetic element carrying the erythromycin resistance determinant erm(TR) in Streptococcus pneumoniae. Antimicrob Agents Chemother (2007) 0.97
Detection of inducible clindamycin resistance in beta-hemolytic streptococci by using the CLSI broth microdilution test and erythromycin-clindamycin combinations. J Clin Microbiol (2010) 0.91
Prevalence, characteristics, and molecular epidemiology of macrolide and fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae at five tertiary-care hospitals in Korea. Antimicrob Agents Chemother (2007) 0.77
Detection of erythromycin-resistant determinants by PCR. Antimicrob Agents Chemother (1996) 10.56
Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland. J Antimicrob Chemother (1993) 4.83
Plasmid copy number control: isolation and characterization of high-copy-number mutants of plasmid pE194. J Bacteriol (1979) 4.65
A novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenes. Antimicrob Agents Chemother (1998) 3.97
Erythromycin resistance genes in group A streptococci in Finland. The Finnish Study Group for Antimicrobial Resistance. Antimicrob Agents Chemother (1999) 2.73
Complete nucleotide sequence and transcription of ermF, a macrolide-lincosamide-streptogramin B resistance determinant from Bacteroides fragilis. J Bacteriol (1986) 2.69
Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains in Italy and heterogeneity of inducibly resistant strains. Antimicrob Agents Chemother (1999) 2.52
Different erythromycin resistance mechanisms in group C and group G streptococci. Antimicrob Agents Chemother (1998) 2.33
Prevalence and mechanisms of macrolide resistance in clinical isolates of group A streptococci from Ontario, Canada. Antimicrob Agents Chemother (1999) 2.01
Cloning and analysis of ermG, a new macrolide-lincosamide-streptogramin B resistance element from Bacillus sphaericus. J Bacteriol (1987) 1.94
Host range of the ermF rRNA methylase gene in bacteria of human and animal origin. J Antimicrob Chemother (1999) 1.57
Cloning and sequence analysis of ermQ, the predominant macrolide-lincosamide-streptogramin B resistance gene in Clostridium perfringens. Antimicrob Agents Chemother (1994) 1.27
Transferable Tet M in Fusobacterium nucleatum. Antimicrob Agents Chemother (1990) 0.98
Tetracycline resistance in Peptostreptococcus species. Antimicrob Agents Chemother (1991) 0.95
Macrolide resistance phenotypes and mechanisms of resistance in Streptococcus pyogenes in La Rioja, Spain. Int J Antimicrob Agents (1999) 0.87
Resistance of Peptostreptococcus spp. to macrolides and lincosamides: inducible and constitutive phenotypes. Antimicrob Agents Chemother (1992) 0.85
Comparative genomics of Listeria species. Science (2001) 12.94
High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science (2000) 9.14
Expression in Escherichia coli and sequence analysis of the listeriolysin O determinant of Listeria monocytogenes. Infect Immun (1988) 6.74
Listeriolysin O is essential for virulence of Listeria monocytogenes: direct evidence obtained by gene complementation. Infect Immun (1989) 5.04
Complex clonal and plasmid epidemiology in the first outbreak of Enterobacteriaceae infection involving VIM-1 metallo-beta-lactamase in Spain: toward endemicity? Clin Infect Dis (2007) 4.51
Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Euro Surveill (2008) 4.03
Mutation frequencies and antibiotic resistance. Antimicrob Agents Chemother (2000) 3.27
Prevalence and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Europe. Clin Microbiol Infect (2008) 3.18
Gene sequence and biochemical characterization of FOX-1 from Klebsiella pneumoniae, a new AmpC-type plasmid-mediated beta-lactamase with two molecular variants. Antimicrob Agents Chemother (1994) 3.09
Nucleotide sequence and characterization of a novel cefotaxime-hydrolyzing beta-lactamase (CTX-M-10) isolated in Spain. Antimicrob Agents Chemother (2001) 2.91
Microcin plasmids: a group of extrachromosomal elements coding for low-molecular-weight antibiotics in Escherichia coli. J Bacteriol (1978) 2.83
Antibiotics as intermicrobial signaling agents instead of weapons. Proc Natl Acad Sci U S A (2006) 2.80
Mycobacterium tuberculosis subsp. caprae subsp. nov.: a taxonomic study of a new member of the Mycobacterium tuberculosis complex isolated from goats in Spain. Int J Syst Bacteriol (1999) 2.63
Antimicrobial susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and their ecological relationships: results of a 1-year (1998-1999) multicenter surveillance study in Spain. Antimicrob Agents Chemother (2001) 2.42
Characterization of a new TEM-type beta-lactamase resistant to clavulanate, sulbactam, and tazobactam in a clinical isolate of Escherichia coli. Antimicrob Agents Chemother (1993) 2.34
Induction of the SOS response by new 4-quinolones. J Antimicrob Chemother (1987) 2.31
Phenotypic tolerance: antibiotic enrichment of noninherited resistance in bacterial populations. Antimicrob Agents Chemother (2005) 2.20
Factors determining resistance to beta-lactam combined with beta-lactamase inhibitors in Escherichia coli. J Antimicrob Chemother (1991) 2.12
New extended-spectrum TEM-type beta-lactamase from Salmonella enterica subsp. enterica isolated in a nosocomial outbreak. Antimicrob Agents Chemother (1995) 1.99
Transmission between HIV-infected patients of multidrug-resistant tuberculosis caused by Mycobacterium bovis. AIDS (1997) 1.98
European recommendations for antimicrobial resistance surveillance. Clin Microbiol Infect (2004) 1.95
Plasmids in Listeria. Plasmid (1982) 1.94
In vitro activities of ertapenem (MK-0826) against recent clinical bacteria collected in Europe and Australia. Antimicrob Agents Chemother (2001) 1.74
Outbreak of a multiresistant Klebsiella pneumoniae strain in an intensive care unit: antibiotic use as risk factor for colonization and infection. Clin Infect Dis (2000) 1.74
Genetic characterization of multidrug-resistant Mycobacterium bovis strains from a hospital outbreak involving human immunodeficiency virus-positive patients. J Clin Microbiol (1997) 1.72
Streptococcus pneumoniae resistance to erythromycin and penicillin in relation to macrolide and beta-lactam consumption in Spain (1979-1997). J Antimicrob Chemother (2000) 1.72
vanA-mediated vancomycin-resistant Enterococcus spp. in sewage. J Antimicrob Chemother (1994) 1.71
Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase. J Med Chem (1998) 1.70
Allele-specific PCR method based on pncA and oxyR sequences for distinguishing Mycobacterium bovis from Mycobacterium tuberculosis: intraspecific M. bovis pncA sequence polymorphism. J Clin Microbiol (1998) 1.66
Antibiotic resistance in Campylobacter strains isolated from animals, foods, and humans in Spain in 1997-1998. Antimicrob Agents Chemother (2000) 1.64
Evaluation of the Wider system, a new computer-assisted image-processing device for bacterial identification and susceptibility testing. J Clin Microbiol (2000) 1.62
Concentration-dependent selection of small phenotypic differences in TEM beta-lactamase-mediated antibiotic resistance. Antimicrob Agents Chemother (2000) 1.55
Resistance to beta-lactam/clavulanate. Lancet (1987) 1.54
International collaborative study on standardization of bacterial sensitivity to fosfomycin. J Antimicrob Chemother (1983) 1.52
Hepatitis E virus: relevance in blood donors and other risk groups. Vox Sang (1998) 1.51
Biological cost of AmpC production for Salmonella enterica serotype Typhimurium. Antimicrob Agents Chemother (2000) 1.50
Streptococcus pyogenes resistance to erythromycin in relation to macrolide consumption in Spain (1986-1997). J Antimicrob Chemother (2000) 1.48
Postantibiotic effect of imipenem on gram-positive and gram-negative micro-organisms. J Antimicrob Chemother (1986) 1.46
Mechanisms of iron acquisition and bacterial virulence. FEMS Microbiol Rev (1990) 1.44
In vitro activity of linezolid against Mycobacterium tuberculosis complex, including multidrug-resistant Mycobacterium bovis isolates. Int J Antimicrob Agents (2006) 1.42
An extended-spectrum AmpC-type beta-lactamase obtained by in vitro antibiotic selection. FEMS Microbiol Lett (1998) 1.40
Single amino acid replacements at positions altered in naturally occurring extended-spectrum TEM beta-lactamases. Antimicrob Agents Chemother (1995) 1.40
The emergence of highly fluoroquinolone-resistant Escherichia coli in community-acquired urinary tract infections. J Antimicrob Chemother (1992) 1.40
beta-Lactam coselection of sensitive and TEM-1 beta-lactamase-producing subpopulations in heterogeneous Escherichia coli colonies. J Antimicrob Chemother (1985) 1.40
Antibiotic therapy of community respiratory tract infections: strategies for optimal outcomes and minimized resistance emergence. J Antimicrob Chemother (2002) 1.37
Healthcare-associated infections: think globally, act locally. Clin Microbiol Infect (2008) 1.35
Escherichia coli and Staphylococcus aureus: bad news and good news from the European Antimicrobial Resistance Surveillance Network (EARS-Net, formerly EARSS), 2002 to 2009. Euro Surveill (2011) 1.34
Small plasmids are involved in amoxicillin-clavulanate resistance in Escherichia coli. Antimicrob Agents Chemother (1989) 1.31
Implication of Ile-69 and Thr-182 residues in kinetic characteristics of IRT-3 (TEM-32) beta-lactamase. Antimicrob Agents Chemother (1996) 1.30
Long-term persistence of ciprofloxacin-resistant Haemophilus influenzae in patients with cystic fibrosis. J Infect Dis (1996) 1.29
Correlation between in vitro resistance to fluconazole and clinical outcome of oropharyngeal candidiasis in HIV-infected patients. Eur J Clin Microbiol Infect Dis (1996) 1.28
Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients. Clin Microbiol Infect (2005) 1.27
Selection of naturally occurring extended-spectrum TEM beta-lactamase variants by fluctuating beta-lactam pressure. Antimicrob Agents Chemother (2000) 1.27
Multicentre evaluation of the VITEK 2 Advanced Expert System for interpretive reading of antimicrobial resistance tests. J Antimicrob Chemother (2002) 1.25
Penicillin-binding protein 3 of Listeria monocytogenes as the primary lethal target for beta-lactams. Antimicrob Agents Chemother (1990) 1.25
Antimicrobial susceptibilities of unique Stenotrophomonas maltophilia clinical strains. Antimicrob Agents Chemother (2001) 1.24
Soft salt-mannitol agar-cloxacillin test: a highly specific bedside screening test for detection of colonization with methicillin-resistant Staphylococcus aureus. J Clin Microbiol (1998) 1.22
A237T as a modulating mutation in naturally occurring extended-spectrum TEM-type beta-lactamases. Antimicrob Agents Chemother (1998) 1.22
Stenotrophomonas maltophilia in cystic fibrosis patients. Eur J Clin Microbiol Infect Dis (1995) 1.21
Evidence to support the rationale that bacterial eradication in respiratory tract infection is an important aim of antimicrobial therapy. J Antimicrob Chemother (2001) 1.18
Characterization of a nosocomial outbreak involving an epidemic plasmid encoding for TEM-27 in Salmonella enterica subspecies enterica serotype Othmarschen. J Infect Dis (1996) 1.17
Leptotrichia buccalis bacteremia in neutropenic children. J Clin Microbiol (1985) 1.12
Quinolone resistance by mutations in chromosomal gyrase genes. Just the tip of the iceberg? J Antimicrob Chemother (1998) 1.12
Mutations in 23S rRNA in Helicobacter pylori conferring resistance to erythromycin do not always confer resistance to clarithromycin. Antimicrob Agents Chemother (1999) 1.11
In vitro selective antibiotic concentrations of beta-lactams for penicillin-resistant Streptococcus pneumoniae populations. Antimicrob Agents Chemother (1994) 1.11
The complexed structure and antimicrobial activity of a non-beta-lactam inhibitor of AmpC beta-lactamase. Protein Sci (1999) 1.11
A multidrug efflux transporter in Listeria monocytogenes. FEMS Microbiol Lett (2000) 1.10
Protein flexibility and conformational state: a comparison of collective vibrational modes of wild-type and D96N bacteriorhodopsin. Biophys J (2003) 1.09
Beta-lactam stability in frozen microdilution PASCO MIC panels using strains with known resistance mechanisms as biosensors. Diagn Microbiol Infect Dis (1996) 1.09
H-NS and RpoS regulate emergence of Lac Ara+ mutants of Escherichia coli MCS2. J Bacteriol (1997) 1.09
Vancomycin-resistant enterococci isolated from animals and food. Int J Food Microbiol (2000) 1.08
Improved method of determining the susceptibility of Candida albicans to fluconazole. J Antimicrob Chemother (1995) 1.08
Influences of different factors on prevalence of ciprofloxacin resistance in Streptococcus pneumoniae in Spain. Antimicrob Agents Chemother (2000) 1.08
Modulation of DNA topology by flaR, a new gene from Listeria monocytogenes. Mol Microbiol (1995) 1.07
Antibiotic resistance in 1962 invasive isolates of Escherichia coli in 27 Spanish hospitals participating in the European Antimicrobial Resistance Surveillance System (2001). J Antimicrob Chemother (2002) 1.05
Efficacy of ampicillin plus ceftriaxone in treatment of experimental endocarditis due to Enterococcus faecalis strains highly resistant to aminoglycosides. Antimicrob Agents Chemother (1999) 1.04
Bacteriocin production in vancomycin-resistant and vancomycin-susceptible Enterococcus isolates of different origins. Antimicrob Agents Chemother (2001) 1.04
Persistence and variability of Stenotrophomonas maltophilia in cystic fibrosis patients, Madrid, 1991-1998. Emerg Infect Dis (2001) 1.04
Nontuberculous mycobacteria in patients with cystic fibrosis. Clin Infect Dis (2001) 1.03
Pharmacoepidemiological analysis of provincial differences between consumption of macrolides and rates of erythromycin resistance among Streptococcus pyogenes isolates in Spain. J Clin Microbiol (2002) 1.02
Genetic and phenotypic differences among Enterococcus faecalis clones from intestinal colonisation and invasive disease. Clin Microbiol Infect (2006) 1.01
Inducible macrolides-lincosamides-streptogramin B resistance in Bacteroides species. Antimicrob Agents Chemother (1987) 1.01
Cloning of two possible haemolysin determinants from Listeria monocytogenes. Ann Inst Pasteur Microbiol (1987) 1.01
Ampicillin-sulbactam and amoxicillin-clavulanate susceptibility testing of Escherichia coli isolates with different beta-lactam resistance phenotypes. Antimicrob Agents Chemother (1999) 0.99
In vitro activity of telithromycin against Spanish Streptococcus pneumoniae isolates with characterized macrolide resistance mechanisms. Antimicrob Agents Chemother (2001) 0.98
Synergistic effect of dosage and bacterial inoculum in TEM-1 mediated antibiotic resistance. Eur J Clin Microbiol Infect Dis (1988) 0.98
Clinicoepidemiologic characteristics, prognostic factors, and survival analysis of patients coinfected with human immunodeficiency virus and Leishmania in an area of Madrid, Spain. Am J Trop Med Hyg (1998) 0.98
Comparison of serotype, biotype and bacteriocin type with rDNA RFLP patterns for the type identification of Serratia marcescens. Epidemiol Infect (1993) 0.98
[Criteria of the MENSURA group for the definition of the critical points of sensitivity to antibiotics]. Enferm Infecc Microbiol Clin (1998) 0.98
PCR-amplified 16S and 23S rDNA restriction analysis for the identification of Acinetobacter strains at the DNA group level. Res Microbiol (1997) 0.97
A protoplast transformation system for Listeria sp. Plasmid (1987) 0.96